Following a drug's trials through approval with ClinicalTracker

For example, you have been following a trial that was listed but not yet enrolling. Checking by hand means opening the page every few days just to see the same status.

With the trial on your watchlist, ClinicalTracker alerts you when its status changes to Recruiting. The alert includes the registry link. You open it, read the eligibility details at the source, and decide whether to raise it with your doctor.

Location often decides whether a trial is realistic. A study that was only running far away may add a site nearer to you, and the registry will not announce it.

A watchlist alert can tell you that new sites were added. You follow the registry link, check where they are, and take the list to your care team if it looks relevant.

A single drug often moves through more than one study. Search for it in ClinicalTracker, then put the relevant trials on your watchlist together.

From then on you hear about changes to any of them in one place. You can follow the drug's progress toward approval without keeping a spreadsheet of registry pages.

If you use a personal AI such as Instinct or Muse, you can have alerts arrive there. ClinicalTracker also offers an MCP connection for AI assistants, described on its own site.

That way you can reply to an alert and ask what to look at next, while the facts still come from the registry link inside the alert.